Clinical Trial Update: HRS-7450 Injection Phase II Clinical Trial for Acute Ischemic Stroke. [Phase 2]

View source ↗

Summary

The update indicates that the Phase II trial of HRS-7450 Injection for acute ischemic stroke is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• HRS-7450

Snippet

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. | Conditions: Acute Ischemic Stroke | Phase 2 | Status: RECRUITING